Cargando…

Open label study of ambrisentan in patients with exercise pulmonary hypertension

A growing body of evidence suggests that exercise pulmonary hypertension (ePH) is an early form of pulmonary arterial hypertension (PAH). Identifying the disease at an early, potentially more responsive phase, and initiating treatment may improve functional status and prevent progression to severe f...

Descripción completa

Detalles Bibliográficos
Autores principales: Segrera, Sergio A., Lawler, Laurie, Opotowsky, Alexander R., Systrom, David, Waxman, Aaron B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467947/
https://www.ncbi.nlm.nih.gov/pubmed/28597763
http://dx.doi.org/10.1177/2045893217709024